Company Filing History:
Years Active: 2019-2020
Title: Angel Baldan: Innovator in Atherosclerosis Therapy
Introduction
Angel Baldan is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of atherosclerosis. With a total of 2 patents, Baldan's work focuses on innovative approaches to combat this prevalent condition.
Latest Patents
Baldan's latest patents include "Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclerosis" and "Systems and methods for inhibiting atherosclerosis using FoxP3+ CD8 T-cells (Tc)." These patents detail a method where osteoclasts are induced to produce FoxP3+ CD8 T-cells through the introduction of a low-dose RANK agonist, such as RANKL. The research indicates that RANKL is most effective when administered in a pulsed manner, enhancing its therapeutic potential.
Career Highlights
Angel Baldan is affiliated with Saint Louis University, where he continues to advance his research in atherosclerosis therapies. His work has garnered attention for its innovative approach and potential impact on cardiovascular health.
Collaborations
Baldan collaborates with esteemed colleagues, including Rajeev Aurora and Anna Smith, who contribute to his research endeavors. Their combined expertise fosters a dynamic research environment focused on groundbreaking medical solutions.
Conclusion
Angel Baldan's contributions to the field of atherosclerosis therapy exemplify the importance of innovation in medical research. His patents reflect a commitment to improving health outcomes through scientific advancement.